Liu RT - Search Results

1

No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.

Liu RT, Chen YJ, Chou FF, Li CL, Wu WL, Tsai PC, Huang CC, Cheng JT. Liu RT, et al. Clin Endocrinol (Oxf). 2005 Oct;63(4):461-6. doi: 10.1111/j.1365-2265.2005.02367.x. Clin Endocrinol (Oxf). 2005. PMID: 16181240

2

Selective occurrence of ras mutations in benign and malignant thyroid follicular neoplasms in Taiwan.

Liu RT, Hou CY, You HL, Huang CC, Hock-Liew, Chou FF, Wang PW, Cheng JT. Liu RT, et al. Thyroid. 2004 Aug;14(8):616-21. doi: 10.1089/1050725041692882. Thyroid. 2004. PMID: 15320975

3

Low prevalence of RET rearrangements (RET/PTC1, RET/PTC2, RET/PTC3, and ELKS-RET) in sporadic papillary thyroid carcinomas in Taiwan Chinese.

Liu RT, Chou FF, Wang CH, Lin CL, Chao FP, Chung JC, Huang CC, Wang PW, Cheng JT. Liu RT, et al. Thyroid. 2005 Apr;15(4):326-35. doi: 10.1089/thy.2005.15.326. Thyroid. 2005. PMID: 15876154

4

Ultra-sensitive detection of mutated papillary thyroid carcinoma DNA using square wave stripping voltammetry method and amplified gold nanoparticle biomarkers.

Liao KT, Cheng JT, Li CL, Liu RT, Huang HJ. Liao KT, et al. Among authors: liu rt. Biosens Bioelectron. 2009 Mar 15;24(7):1899-904. doi: 10.1016/j.bios.2008.09.022. Epub 2008 Oct 8. Biosens Bioelectron. 2009. PMID: 19010660

5

miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation.

Chou CK, Chen RF, Chou FF, Chang HW, Chen YJ, Lee YF, Yang KD, Cheng JT, Huang CC, Liu RT. Chou CK, et al. Among authors: liu rt. Thyroid. 2010 May;20(5):489-94. doi: 10.1089/thy.2009.0027. Thyroid. 2010. PMID: 20406109

6

Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.

Chou CK, Yang KD, Chou FF, Huang CC, Lan YW, Lee YF, Kang HY, Liu RT. Chou CK, et al. Among authors: liu rt. J Clin Endocrinol Metab. 2013 Feb;98(2):E196-205. doi: 10.1210/jc.2012-2666. Epub 2012 Dec 21. J Clin Endocrinol Metab. 2013. PMID: 23264400

7

IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma.

Chou CK, Chi SY, Huang CH, Chou FF, Huang CC, Liu RT, Kang HY. Chou CK, et al. Among authors: liu rt. J Clin Endocrinol Metab. 2016 Nov;101(11):4357-4366. doi: 10.1210/jc.2016-2276. Epub 2016 Aug 17. J Clin Endocrinol Metab. 2016. PMID: 27533309

8

Overexpression of tumor susceptibility gene TSG101 in human papillary thyroid carcinomas.

Liu RT, Huang CC, You HL, Chou FF, Hu CC, Chao FP, Chen CM, Cheng JT. Liu RT, et al. Oncogene. 2002 Jul 18;21(31):4830-7. doi: 10.1038/sj.onc.1205612. Oncogene. 2002. PMID: 12101421

9

Sequential follow-up of serum thyroglobulin and whole body scan in thyroid cancer patients without initial metastasis.

Huang SH, Wang PW, Huang YE, Chou FF, Liu RT, Tung SC, Chen JF, Kuo MC, Hsieh JR, Hsieh HH. Huang SH, et al. Among authors: liu rt. Thyroid. 2006 Dec;16(12):1273-8. doi: 10.1089/thy.2006.16.1273. Thyroid. 2006. PMID: 17199438

10

An upstream regulatory element confers orientation-independent enhancement of the TSG101 promoter activity in transformed cells.

Hsu SF, Goan YG, Tsai HY, Lin YR, Liu RT, Cheng JT. Hsu SF, et al. Among authors: liu rt. Mol Biol Rep. 2012 Jan;39(1):517-25. doi: 10.1007/s11033-011-0766-6. Epub 2011 May 10. Mol Biol Rep. 2012. PMID: 21556761

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters